Ondine Biomedical Inc. NPV (CDI) (OBI) RNS Announcements

Add to Alert list
Date Time Source Announcement
20 Dec 2021 07:00 AM
RNS
Ondine and University of Navarra initiate clinical
15 Dec 2021 07:00 AM
RNS
Ondine Biomedical appoints Professor Trevor Jones
07 Dec 2021 07:00 AM
RNS
Ondine Biomedical appoints new Board of Directors
06 Dec 2021 07:00 AM
RNS
Ondine Biomedical announces AIM market listing

Ondine Biomedical is a Canadian life sciences company that develops light-activated antimicrobial therapies called photodisinfection to prevent and treat infections, including those from drug-resistant bacteria.

It is listed on LSE under the ticker OBI.

OBI share price launched at 59p in 2021.

UK 100

Latest directors dealings